DiagCor Life Science Limited

DiagCor Life Science Limited Dedicated solely to molecular diagnostics.

DiagCor Life Science wishes you good fortune, longevity and prosperity in the Year of the Dragon!
09/02/2024

DiagCor Life Science wishes you good fortune, longevity and prosperity in the Year of the Dragon!

Yuletide greetings to all of our friends and partners around the world! Wishing everyone happy holidays and continued su...
22/12/2023

Yuletide greetings to all of our friends and partners around the world! Wishing everyone happy holidays and continued success in 2024!

Festive greetings to all of our friends and partners around the globe! Wishing everyone continued success in 2023!
21/12/2022

Festive greetings to all of our friends and partners around the globe! Wishing everyone continued success in 2023!

24/11/2022

GenoFlow™ HPV Array 100% Proficient in latest QCMD EQA Programme (November 2022)

The QCMD (Quality Control for Molecular Diagnostics, www.qcmd.org) is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation. QCMD provides a wide-ranging quality assessment service primarily focused on molecular infectious diseases to over 2000 participants in over 100 countries. Their Human Papillomavirus (PreservCyt) EQA Programme assesses the proficiency of laboratories in the detection of different high risk HPV types within a PreservCyt® matrix.

In the latest November 2022 programme, laboratory using DiagCor’s GenoFlow™ HPV Array, together with DiagPuro™ Nucleic Acid Extraction System and DiagPuro™ Viral DNA/RNA Extraction Reagent has participated and attained fully proficient (100% proficient) status. In addition to the HPV subtypes covered by the proficiency programme, GenoFlow™ HPV Array Test Kit can genotype a total of 33 high- and low-risk HPV subtypes. DiagCor Life Science prioritizes high product quality and actively supports HPV genotyping services in laboratories worldwide.

Find the full details of the kit on the product page, or get in touch to learn more!

21/07/2022

Improved performance of GenoImmu™ COVID-19 Antigen Detection Kit

DiagCor Life Science is happy to report improved performance of our CE-IVD marked GenoImmu™ COVID-19 Antigen Detection Kit.

● Rapid – Result in 15-20 minutes
● Accurate – Sensitivity ≥ 96%, Specificity ≥ 99%

In addition, the kit is able to detect SARS-CoV-2 variants such as Delta and Omicron.

Please see our product page or contact us directly for more details.

DiagCor Life Science wishes you health and good fortune in the Year of the Tiger!
31/01/2022

DiagCor Life Science wishes you health and good fortune in the Year of the Tiger!

17/01/2022

New study uses GenoFlow™ HPV Array Test Kit to highlight the importance of HPV disease awareness and testing in men, with implications for male HPV vaccination and prevention of a**l cancer

A new collaborative study between researchers in the UK, Australia, Canada, Hong Kong and Vietnam describes a**l HPV prevalence among certain groups of higher-risk Vietnamese men. Among men who have s*x with men (‘MSM’), it was found that one in four had at least one high-risk HPV genotype; persistent infection with high-risk a**l HPV genotypes is a real risk for a**l cancer. The genotyping capabilities of our GenoFlow™ HPV Array Test Kit identified HPV52, HPV39, and HPV66/68 as the most prevalent high-risk subtypes among the study participants. Men in general are often overlooked when considering HPV testing and infection, and the authors highlight that MSM in particular are at higher risk of HPV-related disease compared to other men. Continued medical education is needed globally to highlight the importance and benefits of the GenoFlow™ HPV Array Test Kit for HPV genotyping in both women and men.

Reference: Tuan LA, Prem K, Pham QD, Toh ZQ, Tran HP, Nguyen PD, Mai CTN, Ly LTK, Cao V, Le-Ha TD, Tuan NA, Jit M, Bright K, Brisson M, Nguyen TV, Garland S, Anh DD, Trang NV, & Mulholland K (2021). A**l human papillomavirus prevalence and risk factors among men who have s*x with men in Vietnam. Int J Infect Dis. 112:136-143.

Seasonal greetings from the DiagCor Life Science team. Enjoy the holidays and we hope to see all of you in person in 202...
23/12/2021

Seasonal greetings from the DiagCor Life Science team. Enjoy the holidays and we hope to see all of you in person in 2022!

21/12/2021

Hong Kong registered clinical diagnostic laboratory, using DiagCor Life Science’s COVID-19 testing IVD products, received 100% concordance results in the latest HKSAR Department of Health QAP (December 2021 Program)

A Hong Kong registered clinical diagnostic laboratory has used DiagCor Life Science’s COVID-19 Testing IVD products to participate in the HKSAR Department of Health’s December 2021 SARS-CoV-2 Quality Assurance Program, achieving 100% concordance results. The laboratory used DiagCor Life Science’s DiagPuro™ Nucleic Acid Extraction System, DiagPuro™ Viral DNA/RNA Extraction Reagent and GenoScreen™ SARS-CoV-2 RT-qPCR Assay. The samples included in this SARS-CoV-2 QAP were prepared by Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, HKSAR Government. They are frozen transport medium samples with or without inactivated SARS-CoV-2 (whole virus).

15/12/2021

GenoScreen™ SARS-CoV-2 RT-qPCR Assay remains highly accurate in testing the Omicron variant

The newest variant of concern Omicron (B.1.1.529) contains over 30 reported mutations in the S gene, with implications for receptor binding and transmissibility as well as antibody escape and immune evasion. It is therefore important to show that the diagnostic accuracy of SARS-CoV-2 assays is not affected. After detailed in silico a**lysis of the available sequences in variant databases such as GISAID (as at 10/12/2021), DiagCor Life Science is happy to report that none of the mutations associated with the Omicron variant affects our GenoScreen™ SARS-CoV-2 RT-qPCR Assay. Clinical laboratories using this assay can proceed with confidence for their testing operations.

Product Launch – DiagPuro™ Nucleic Acid Extraction System & Extraction ReagentDiagCor Life Science is proud to introduce...
06/12/2021

Product Launch – DiagPuro™ Nucleic Acid Extraction System & Extraction Reagent

DiagCor Life Science is proud to introduce the CE-IVD marked DiagPuro™ Nucleic Acid Extraction System and accompanying DiagPuro™ Viral DNA/RNA Extraction Reagent. The platform provides an efficient, automated and high quality nucleic acid purification solution for a wide range of specimen types, for downstream genetic a**lysis and molecular diagnostics. It is useful for MDx service labs, healthcare institutions and research labs around the world.

The system is based on magnetic bead adsorption technology, and can extract up to 32 samples simultaneously. Please visit the instrument and reagent product pages to learn more. Together with the DiagPuro™ Direct Cell Lysis DNA Extraction Reagent, the DiagPuro™ product line now represents a complete range of manual and automated extraction options.

DiagPuro™ Nucleic Acid Extraction System:
http://www.diagcorlifescience.com/en/mdx-products/detail/diagpuro-sup-tm-sup-nucleic-acid-extraction-system

DiagPuro™ Viral DNA/RNA Extraction Reagent:
http://www.diagcorlifescience.com/en/mdx-products/detail/viral-dna-rna-extraction-reagent

DiagPuro™ Direct Cell Lysis DNA Extraction Reagent:
http://www.diagcorlifescience.com/en/mdx-products/detail/direct-cell-lysis-dna-extraction-reagent

GenoScreen™ SARS-CoV-2 RT-qPCR Assay again 100% Proficient in latest QCMD EQA Programme (October 2021)The QCMD (Quality ...
30/11/2021

GenoScreen™ SARS-CoV-2 RT-qPCR Assay again 100% Proficient in latest QCMD EQA Programme (October 2021)

The QCMD (Quality Control for Molecular Diagnostic) is an external quality assurance programme that helps to monitor and improve quality within clinical laboratories. Their SARS-CoV-2 EQA programme assesses the sensitivity of assays routinely used for molecular detection of SARS-CoV-2 at clinically appropriate levels, near the limit of detection as well as the specificity of assays in the presence of other human coronaviruses.

In the latest October 2021 programme, laboratory using DiagCor’s GenoScreen™ SARS-CoV-2 qRT-PCR Assay, together with DiagPuro™ Nucleic Acid Extraction System and Genesis 96Q Real-time PCR System) has participated and attained fully proficient (100% proficient) status. SARS-CoV-2 variants (B.1, B1.1.7 & B1.351) were being successfully detected. DiagCor Life Science prioritizes high product quality and actively supports SARS-CoV-2 testing services in laboratories worldwide, thus contributing to fight against COVID-19.

Find the full details on the DiagCor Life Science website's product pages http://www.diagcorlifescience.com/en/mdx-products or get in touch to learn more!

Address

Unit 1380, 13/F, KITEC, 1 Trademart Drive, Kowloon Bay, Kowloon
Hong Kong
N/A

Alerts

Be the first to know and let us send you an email when DiagCor Life Science Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share